Quick Answer
IMMUCELL CORP /DE/ reported Operating Income of $1.65 million for fiscal year 2025.
IMMUCELL CORP /DE/ Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $1.65M | +200.6% |
| 2024 | -$1.64M | +71.5% |
| 2023 | -$5.75M | -150.0% |
| 2022 | -$2.30M | -993.2% |
| 2021 | $257.4K | +118.6% |
| 2020 | -$1.38M | -44.7% |
| 2019 | -$953.9K | +34.1% |
| 2018 | -$1.45M | -495.7% |
| 2017 | -$242.8K | -127.3% |
| 2016 | $890.2K | -58.1% |
| 2015 | $2.12M | +1128.3% |
| 2014 | -$206.4K | -955.6% |
| 2013 | -$19.6K | -108.0% |
| 2012 | $245.0K | +138.7% |
| 2011 | -$632.7K | +8.3% |
| 2010 | -$690.3K | -30.3% |
| 2009 | -$529.9K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $20.1K | +103.5% | -96.5% |
| June 30, 2025 | $569.6K | +141.1% | -49.0% |
| March 31, 2025 | $1.12M | +472.5% | +294.4% |
| September 30, 2024 | -$574.9K | +51.4% | +58.5% |
| June 30, 2024 | -$1.39M | -6.3% | -362.1% |
| March 31, 2024 | -$300.1K | +86.7% | +74.7% |
| September 30, 2023 | -$1.18M | -92.0% | +9.2% |
| June 30, 2023 | -$1.30M | -110.7% | +42.2% |
- IMMUCELL CORP /DE/ showed an increase of +200.6% in Operating Income compared to the prior fiscal year.
- Over the 2009–2025 period, IMMUCELL CORP /DE/’s operating income has grown by 411.2% (from -$529.9 thousand to $1.65 million).
- The most recent figure is from IMMUCELL CORP /DE/’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: